New hope for patients out of options: immune therapy tested for aggressive blood cancer
NCT ID NCT05228470
Summary
This study tested a new drug called Elranatamab for Chinese patients with a severe form of multiple myeloma that no longer responds to standard treatments. The drug is an injection that works by activating the body's own immune system to attack the cancer cells. The trial had two parts: first to find a safe dose, and then to see how well the drug worked at controlling the disease over about two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Gaobo Boren Hospital
Beijing, 100070, China
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, 350001, China
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510080, China
-
Harbin First Hospital
Harbin, Heilongjiang, 150010, China
-
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, 150081, China
-
Hematology Hospital, Chinese Academy of Medical Sciences
Tianjin, 300020, China
-
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, 510515, China
-
Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, 210008, China
-
Peking Union Medical College Hospital
Beijing, 100730, China
-
Peking University Third Hospital
Beijing, 100191, China
-
Shandong Provincial Hospital
Jinan, Shandong, 250021, China
-
Shenzhen Second People's Hosptial
Shenzhen, Guangdong, 518035, China
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510555, China
-
The First Affiliated Hospital of College of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310003, China
-
The First Hospital of Jilin University
Changchun, Jilin, 130021, China
Conditions
Explore the condition pages connected to this study.